IASO Bio Establishes International Partnership with Instituto Butantan to Develop Innovative Therapy for Hematological Cancer

The agreement aims to expand access to the therapy in Brazil; The Technology is for patients who did not respond to conventional treatments. SHANGHAI and NANJING, China and PLEASANTON, Calif., April 10, 2026 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), today announced that it has...